- Company Directors - G
- Greenacre Martyn D
Insider Trading History of Greenacre Martyn D
The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Greenacre Martyn D since 2005.
The trader's CIK number is 1209727.
At the time of the last reporting, Greenacre Martyn D was the Director of Curis Inc. (stock ticker symbol CRIS).
Also see all insider trading activities at Curis Inc.
Note that in the past
GREENACRE MARTYN D also reported insider trading activities as an insider of the following companies:
Yearly summary of insider trading at Acusphere Inc (ACUS) by Greenacre Martyn D
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2007 | ACUS | 10,000 | $25,650 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Curis Inc (CRIS) by Greenacre Martyn D
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2019 | CRIS | 0 | $0 | 18,500 | $19,480 | 0 | $0 |
| 2017 | CRIS | 0 | $0 | 0 | $0 | 15,000 | $20,850 |
| 2016 | CRIS | 0 | $0 | 15,000 | $25,350 | 15,000 | $25,050 |
| 2013 | CRIS | 0 | $0 | 60,000 | $220,200 | 60,000 | $65,400 |
| 2012 | CRIS | 0 | $0 | 130,000 | $609,099 | 130,000 | $158,100 |
Yearly summary of insider trading at Cephalon Inc (CEPH) by Greenacre Martyn D
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2011 | CEPH | 0 | $0 | 10,000 | $797,150 | 10,000 | $639,800 |
| 2010 | CEPH | 0 | $0 | 10,000 | $706,500 | 10,000 | $592,500 |
| 2008 | CEPH | 0 | $0 | 10,000 | $740,200 | 10,000 | $111,870 |
| 2007 | CEPH | 0 | $0 | 10,000 | $781,475 | 10,000 | $123,750 |
| 2006 | CEPH | 0 | $0 | 20,000 | $1,406,755 | 20,000 | $389,680 |
Yearly summary of insider trading at Beijing Med Pharm Corp (BJGP) by Greenacre Martyn D
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2009 | BJGP | 5,000 | $19,725 | 0 | $0 | 0 | $0 |
| 2005 | BJGP | 17,000 | $25,160 | 0 | $0 | 0 | $0 |
Yearly summary of insider trading at Phase Iii Medical Inc/de (NBS) by Greenacre Martyn D
| | Insider Buying | Insider Sales | Option Exercises |
|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
|---|
| 2012 | NBS | 250,000 | $0 | 0 | $0 | 0 | $0 |
Insider trading activities at 5 companies by Greenacre Martyn D:
1. Acusphere Inc (ACUS)
2. Curis Inc (CRIS)
3. Cephalon Inc (CEPH)
4. Beijing Med Pharm Corp (BJGP)
5. Phase Iii Medical Inc/de (NBS)
Table 1. Insider trading of Acusphere Inc (ACUS) by Greenacre Martyn D
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2007-05-16 | ACUS | Buy | 10,000 | 2.56 | 25,650 |
Table 2. Insider trading of Curis Inc (CRIS) by Greenacre Martyn D
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2019-01-23 | CRIS | Sale | 18,500 | 1.05 | 19,480 |
| 2017-05-31 | CRIS | Option Ex | 15,000 | 1.39 | 20,850 |
| 2016-05-27 | CRIS | Option Ex | 15,000 | 1.67 | 25,050 |
| 2016-05-27 | CRIS | Sale | 15,000 | 1.69 | 25,350 |
| 2013-05-02 | CRIS | Option Ex | 60,000 | 1.09 | 65,400 |
| 2013-05-02 | CRIS | Sale | 60,000 | 3.67 | 220,200 |
| 2012-09-19 | CRIS | Option Ex | 50,000 | 1.09 | 54,500 |
| 2012-09-19 | CRIS | Sale | 50,000 | 4.31 | 215,499 |
| 2012-03-28 | CRIS | Option Ex | 80,000 | 1.29 | 103,600 |
| 2012-03-28 | CRIS | Sale | 80,000 | 4.92 | 393,600 |
Table 3. Insider trading of Cephalon Inc (CEPH) by Greenacre Martyn D
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2011-05-09 | CEPH | Option Ex | 10,000 | 63.98 | 639,800 |
| 2011-05-09 | CEPH | Sale | 10,000 | 79.72 | 797,150 |
| 2010-03-02 | CEPH | Option Ex | 10,000 | 59.25 | 592,500 |
| 2010-03-02 | CEPH | Sale | 10,000 | 70.65 | 706,500 |
| 2008-08-01 | CEPH | Option Ex | 10,000 | 11.19 | 111,870 |
| 2008-08-01 | CEPH | Sale | 10,000 | 74.02 | 740,200 |
| 2007-12-03 | CEPH | Sale | 5,000 | 74.86 | 374,325 |
| 2007-12-03 | CEPH | Option Ex | 5,000 | 12.38 | 61,875 |
| 2007-05-30 | CEPH | Sale | 5,000 | 81.43 | 407,150 |
| 2007-05-30 | CEPH | Option Ex | 5,000 | 12.38 | 61,875 |
| 2006-09-05 | CEPH | Option Ex | 5,000 | 12.88 | 64,375 |
| 2006-09-05 | CEPH | Sale | 5,000 | 58.02 | 290,080 |
| 2006-02-17 | CEPH | Option Ex | 15,000 | 21.69 | 325,305 |
| 2006-02-17 | CEPH | Sale | 15,000 | 74.44 | 1,116,675 |
Table 4. Insider trading of Beijing Med Pharm Corp (BJGP) by Greenacre Martyn D
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2009-08-14 | BJGP | Buy | 5,000 | 3.94 | 19,725 |
| 2005-11-28 | BJGP.PK | Buy | 17,000 | 1.48 | 25,160 |
Table 5. Insider trading of Phase Iii Medical Inc/de (NBS) by Greenacre Martyn D
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|
| 2012-05-11 | NBS | Buy | 250,000 | .00 | 0 |
Insider trading activities including stock purchases, stock sales, and option exercises
listed in the above table cannot be completely guaranteed as to their accuracy.
For more information regarding the trades made by Greenacre Martyn D
(Director of Curis Inc at the time of this reporting) see
the Securities and Exchange Commission (SEC) website.